Ribavirin is effective against drug-resistant H7N9 influenza virus infections.
10.1007/s13238-016-0287-0
- Author:
Yuhai BI
1
;
Gary WONG
2
;
Yingxia LIU
3
;
Lei LIU
3
;
George F GAO
2
;
Yi SHI
4
Author Information
1. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. beeyh@im.ac.cn.
2. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
3. Shenzhen Key Laboratory of Pathogen and Immunity, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Shenzhen, 518112, China.
4. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. shiyi@im.ac.cn.
- Publication Type:Letter
- MeSH:
Animals;
Dogs;
Drug Resistance, Viral;
drug effects;
Female;
Humans;
Influenza A Virus, H7N9 Subtype;
Madin Darby Canine Kidney Cells;
Male;
Orthomyxoviridae Infections;
drug therapy;
Ribavirin;
pharmacology
- From:
Protein & Cell
2016;7(8):611-614
- CountryChina
- Language:English
